Rockwell Medical Inc. Company Profile
NASDAQ: RMTIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Rockwell Medical at a glance
Rockwell Medical Inc. (NASDAQ: RMTI) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Wixom, MI. Rockwell Medical is led by Dr. Mark Strobeck Ph.D. and employs about 157 people. The company's shares have traded publicly since 1998.
At a market capitalization of $32.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001041024, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Rockwell Medical do?
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. In addition, it offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
Business description based on the company's public filings.
Company information
- Legal name
- Rockwell Medical Inc.
- Ticker
- NASDAQ: RMTI
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Mark Strobeck Ph.D.
- Employees
- 157
- Headquarters
- 30142 South Wixom road, Wixom, MI, United States
- Phone
- 248 960 9009
- Website
- rockwellmed.com
- IPO year
- 1998
- Market cap
- $32.32M
- SEC CIK
- 0001041024
- Latest annual report
- 10-K · Mar 26, 2026
Companies similar to Rockwell Medical
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NXTCNextCure Inc. | 7.18 | +5.90% | $32.87M | vs RMTI |
| RNAZTransCode Therapeutics Inc. | 1.86 | +8.77% | $31.49M | vs RMTI |
| NNVCNanoViricides Inc. | 1.30 | -0.76% | $33.18M | vs RMTI |
| MIRAMIRA Pharmaceuticals Inc. | 0.7455 | +6.05% | $31.33M | vs RMTI |
| BCTXBriaCell Therapeutics Corp. | 3.91 | -0.13% | $34.02M | vs RMTI |
| ATNMActinium Pharmaceuticals Inc. (Delaware) | 1.10 | +1.85% | $34.59M | vs RMTI |
| GRDXGridAI Technologies Corp. | 4.97 | +3.54% | $35.44M | vs RMTI |
| IGCIGC Pharma Inc. | 0.2799 | -1.75% | $28.94M | vs RMTI |